Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

1 Publication

Publications	Citations
Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study. Schuurbiers MMF, Smith CG, Hartemink KJ, Rintoul RC, Gale D, Monkhorst K, Mandos BLR, Paterson AL, van den Broek D, Rosenfeld N, van den Heuvel MM, LEMA Study Group and the LUCID Study Group. PLoS Med 22: 2025 e1004574	5